These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 18677775)

  • 1. Ursodeoxycholic acid for primary biliary cirrhosis.
    Gong Y; Huang ZB; Christensen E; Gluud C
    Cochrane Database Syst Rev; 2008 Jul; (3):CD000551. PubMed ID: 18677775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ursodeoxycholic acid for primary biliary cirrhosis.
    Rudic JS; Poropat G; Krstic MN; Bjelakovic G; Gluud C
    Cochrane Database Syst Rev; 2012 Dec; 12(12):CD000551. PubMed ID: 23235576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ursodeoxycholic acid for primary biliary cirrhosis.
    Gluud C; Christensen E
    Cochrane Database Syst Rev; 2002; (1):CD000551. PubMed ID: 11869580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ursodeoxycholic acid for patients with primary biliary cirrhosis: an updated systematic review and meta-analysis of randomized clinical trials using Bayesian approach as sensitivity analyses.
    Gong Y; Huang Z; Christensen E; Gluud C
    Am J Gastroenterol; 2007 Aug; 102(8):1799-807. PubMed ID: 17459023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bezafibrate for primary biliary cirrhosis.
    Rudic JS; Poropat G; Krstic MN; Bjelakovic G; Gluud C
    Cochrane Database Syst Rev; 2012 Jan; 1(1):CD009145. PubMed ID: 22259000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colchicine for primary biliary cirrhosis.
    Gong Y; Gluud C
    Cochrane Database Syst Rev; 2004; (2):CD004481. PubMed ID: 15106254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological interventions for primary biliary cholangitis: an attempted network meta-analysis.
    Saffioti F; Gurusamy KS; Eusebi LH; Tsochatzis E; Davidson BR; Thorburn D
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011648. PubMed ID: 28350426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate for primary biliary cirrhosis.
    Giljaca V; Poropat G; Stimac D; Gluud C
    Cochrane Database Syst Rev; 2010 May; (5):CD004385. PubMed ID: 20464729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisphosphonates for osteoporosis in primary biliary cirrhosis.
    Rudic JS; Giljaca V; Krstic MN; Bjelakovic G; Gluud C
    Cochrane Database Syst Rev; 2011 Dec; (12):CD009144. PubMed ID: 22161446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effects of mid-dose ursodeoxycholic acid in primary biliary cirrhosis: a meta-analysis of randomized controlled trials.
    Shi J; Wu C; Lin Y; Chen YX; Zhu L; Xie WF
    Am J Gastroenterol; 2006 Jul; 101(7):1529-38. PubMed ID: 16863557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methotrexate for primary biliary cirrhosis.
    Gong Y; Gluud C
    Cochrane Database Syst Rev; 2005 Jul; (3):CD004385. PubMed ID: 16034929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis.
    Goulis J; Leandro G; Burroughs AK
    Lancet; 1999 Sep; 354(9184):1053-60. PubMed ID: 10509495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination therapy of ursodeoxycholic acid and budesonide for PBC-AIH overlap syndrome: a meta-analysis.
    Zhang H; Yang J; Zhu R; Zheng Y; Zhou Y; Dai W; Wang F; Chen K; Li J; Wang C; Li S; Liu T; Abudumijiti H; Zhou Z; Wang J; Lu W; Wang J; Xia Y; Zhou Y; Lu J; Guo C
    Drug Des Devel Ther; 2015; 9():567-74. PubMed ID: 25632224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination therapy of fenofibrate and ursodeoxycholic acid in patients with primary biliary cirrhosis who respond incompletely to UDCA monotherapy: a meta-analysis.
    Zhang Y; Li S; He L; Wang F; Chen K; Li J; Liu T; Zheng Y; Wang J; Lu W; Zhou Y; Yin Q; Xia Y; Zhou Y; Lu J; Guo C
    Drug Des Devel Ther; 2015; 9():2757-66. PubMed ID: 26045661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bile acids for primary sclerosing cholangitis.
    Poropat G; Giljaca V; Stimac D; Gluud C
    Cochrane Database Syst Rev; 2011 Jan; 2011(1):CD003626. PubMed ID: 21249655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bile acids for primary sclerosing cholangitis.
    Chen W; Gluud C
    Cochrane Database Syst Rev; 2003; (2):CD003626. PubMed ID: 12804480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bile acids for liver-transplanted patients.
    Poropat G; Giljaca V; Stimac D; Gluud C
    Cochrane Database Syst Rev; 2010 Mar; (3):CD005442. PubMed ID: 20238339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone replacement for osteoporosis in women with primary biliary cirrhosis.
    Rudic JS; Poropat G; Krstic MN; Bjelakovic G; Gluud C
    Cochrane Database Syst Rev; 2011 Dec; (12):CD009146. PubMed ID: 22161447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of pretransplantation ursodeoxycholic acid therapy on the outcome of liver transplantation in patients with primary biliary cirrhosis.
    Heathcote EJ; Stone J; Cauch-Dudek K; Poupon R; Chazouilleres O; Lindor KD; Petz J; Dickson ER; Poupon RE
    Liver Transpl Surg; 1999 Jul; 5(4):269-74. PubMed ID: 10388499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged follow-up of patients in the U.S. multicenter trial of ursodeoxycholic acid for primary biliary cirrhosis.
    Combes B; Luketic VA; Peters MG; Zetterman RK; Garcia-Tsao G; Munoz SJ; Lin D; Flye N; Carithers RL
    Am J Gastroenterol; 2004 Feb; 99(2):264-8. PubMed ID: 15046215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.